GSF
ABBV icon

Grove Street Fiduciary’s AbbVie ABBV Stock Holding History

Grove Street Fiduciary’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688K Hold
2,733
– – 0.29% 41
2026
Q1 		$594K Hold
2,733
– – 0.26% 41
2025
Q4 		$624K Hold
2,733
– – 0.26% 39
2025
Q3 		$633K Hold
2,733
– – 0.3% 36
2025
Q2 		$507K Sell
2,733
-16
-0.6% -$2.97K 0.24% 38
2025
Q1 		$576K Buy
+2,749
New +$534K 0.29% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Grove Street Fiduciary's ABBV Position: Q2 2026 in Review

Grove Street Fiduciary held its AbbVie (ABBV) position steady in Q2 2026 at 2,733 shares worth $688K. The position accounts for 0.29% of the portfolio, ranked #41.

Grove Street Fiduciary first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Grove Street Fiduciary held 2,733 shares of AbbVie worth $688K as of Q2 2026.
  • Grove Street Fiduciary left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.29% of Grove Street Fiduciary's portfolio in Q2 2026, its #41 holding.
  • Grove Street Fiduciary first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Grove Street Fiduciary's 13F filing for Q2 2026, filed 23 Jul 2026.